Sasha Damouni Ellis
Sasha Damouni Ellis

Vir Biotechnology brings on Sasha Damouni Ellis as EVP and chief corporate affairs officer, effective July 10. Damouni Ellis joins the company from Marinus Pharmaceuticals, where she was senior VP, corporate affairs and investor relations. She has also served as director of external communications and media relations for Bayer U.S. and worked as a senior healthcare journalist at Bloomberg News and global editor of BioPharm Insight. In her new post. Damouni Ellis will be responsible for Vir’s strategic approach to corporate communications, government affairs, investor relations and patient advocacy, as well as for establishing the company’s corporate social responsibility and environmental, social and governance efforts. “Sasha has an impressive track record as both a corporate communications and investor relations leader,” said Vir CEO Marianne De Backer.

Stephanie Cau
Stéphanie Cau

Renault Group hires Stéphanie Cau as CCO effective July 17. Cau most recently served as senior VP—CSR, brand & communications at testing, inspection and certification multinational Bureau Veritas. She was previously head of brand and communications at Oberthur Technologies and marketing manager at Groupe Bon Marché. At Renault, she will lead global communications for the group and its brands (Renault, Dacia, Alpine, Mobilize).

Jerry Tillery
Jerry JK Tillery

The Colorectal Cancer Alliance adds Jerry J.K. Tillery to its executive team as the organization’s first chief impact officer. Tillery was most recently a senior VP at the American Red Cross. He previously served as VP, operations at Wellstar Health Systems and senior manager, strategic planning and marketing at Emory Healthcare. At the Alliance, Tillery is tasked with ensuring the success of the organization’s programmatic and operational functions as it works to reach a broader population. “Jerry’s unique career path and his unwavering dedication to service position him for incredible impact as we harness the power of the communities we serve to end colorectal cancer,” said Alliance CEO Michael Sapienza.